Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 20/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | SHBG | P04278 | 1/20 | 0.46 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12794297 | 0.89 | CYP19A1 (0.52) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL12794303 | 0.89 | CYP19A1 (0.52) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL6832273 | 0.86 | CYP19A1 (0.65) | CYP19A1ALDH1A1SHBGSERPINA6 | |
| SCHEMBL3658069 | 0.86 | CYP19A1 (0.65) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL9130696 | 0.86 | CYP19A1 (0.65) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL8209838 | 0.84 | CYP19A1 (0.62) | CYP19A1 | |
| SCHEMBL9948623 | 0.81 | CYP19A1 (0.44) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL3660113 | 0.80 | CYP19A1 (0.58) | CYP19A1 | |
| SCHEMBL20088312 | 0.80 | CYP19A1 (1.00) | CYP19A1ALDH1A1LMNASHBGSERPINA6 | |
| SCHEMBL12413521 | 0.80 | CYP19A1 (1.00) | CYP19A1ALDH1A1LMNASHBGSERPINA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1212345-A2 | ORALLY ACTIVE 7.ALPHA.-ALKYL ANDROGENS | Akzo Nobel N.V. (NL) | 2002-06-12 | — | — | EP | disclosed |
| WO-2000059920-A2 | ORALLY ACTIVE 7.ALPHA.-ALKYL ANDROGENS | AKZO NOBEL N.V. (NL) | 2000-10-12 | — | — | WO | disclosed |